Transforming growth factor-βS in neurodegenerative disease

Progress in Neurobiology

Volumn 54, Issue 1, 1998, Pages 71-85

  Flanders, Kathleen C ^a   Ren, Reneé F ^a   Lippa, Carol F ^b  

^a Laboratory of Chemoprevention   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMYLOID BETA PROTEIN; ANTIOXIDANT; NEUROTOXIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ASTROCYTE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PROTECTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW; WOUND HEALING;

EID: 0031975391     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00066-X     Document Type: Article

References (101)

1. Abe K., Chu P.-J., Ishihara A., Saito H. Transforming growth factor-β1 promotes re-elongation of injured axons of cultured rat hippocampal neurons. Brain Res. 723:1996;206-209.
2. Ata A. K., Funa K., Olsson Y. Expression of various TGF-β isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol. 93:1997;326-333.
3. Baghdessarian D., Toru-Delbauffe D., Gavaret J. M., Pieer M. Effects of transforming growth factor-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia. 7:1993;193-202.
4. Blottner D., Wolf N., Lachmund A., Flanders K. C., Unsicker K. TGF-β rescues target-derived preganglionic sympathetic neurons in the spinal cord. Eur. J. Neurosci. 8:1996;202-210.
5. Bottner M., Unsicker K., Suter-Crazzolara C. Expression of the TGF-beta type II receptor mRNA in the CNS. NeuroReport. 7:1996;2903-2907.
6. Buchman V. L., Sporn M., Davies A. M. Role of transforming growth factor-beta isoforms in regulating the expression of nerve growth factor and neurotrophin-3 mRNA levels in embryonic cutaneous cells at different stages of development. Development. 120:1994;1621-1629.
7. Burt D. W., Law A. S. Evolution of the transforming growth factor-β superfamily. Prog. Growth Factor Res. 5:1994;99-118.
8. Chao C. C., Hu S., Tsang M., Weatherbee J. M., Molitor T. W., Anderson W. R., Peterson P. K. Effects of transforming growth factor-β on murine astrocyte glutamine synthetase activity. J. Clin. Invest. 90:1992;1786-1793.
9. Chao C. C., Hu S., Frey W. H., Ala T. A., Tourtellotte W. W., Peterson P. K. Transforming growth factor-β in Alzheimer's disease. Clin. Diagnos. Lab. Immunol. 1:1994;109-110.
10. Chao C. C., Hu S., Kravitz F. H., Tsang M., Anderson W. R., Peterson P. K. Transforming growth factor-β protects human neurons against β-amyloid-induced injury. Mol. Chem. Neuropathol. 23:1994;159-178.
11. Daopin S., Piez K. A., Ogawa Y., Davies D. R. Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science. 257:1992;369-373.
12. de Caestecker M. P., Hemmati P., Larisch-Bloch S., Ajmera R., Roberts A. B., Lechleider R. J. Characterization of functional domains within Smad4/DPC4. J. Biol. Chem. 272:1997;13690-13696.
13. de Luca A., Weller M., Fontana A. TGF-β-induced apoptosis of cerebellar granule neurons is prevented by depolarization. J. Neurosci. 16:1996;4174-4185.
14. Falanga V., Qian S. W., Danielpour D., Katz M. H., Roberts A. B., Sporn M. B. Hypoxia upregulates the synthesis of TGF-β1 by human dermal fibroblasts. J. Invest. Dermatol. 97:1991;634-637.
15. Flanders K. C., Lüdecke G., Engels S., Cissel D. S., Roberts A. B., Kondaiah P., Lafyatis R., Sporn M. B., Unsicker K. Localizations and actions of transforming growth factor-βs in the embryonic nervous system. Development. 113:1991;183-191.
16. Flanders K. C., Lüdecke G., Renzig J., Hamm C., Cissel D. S., Unsicker K. Effect of TGF-βs and bFGF on astroglial cell growth and gene expresssion in vitro. Mol. Cell. Neurosci. 4:1993;406-417.
17. Flanders K. C., Lippa C. F., Smith T. W., Pollen D. A., Sporn M. B. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology. 45:1995;1561-1569.
18. Frautschy S. A., Yang F., Calderon L., Cole G. M. Rodent models of Alzheimer's disease: rat Aβ infusion approaches to amyloid deposits. Neurobiol. Aging. 17:1996;311-321.
19. Galbreath E., Kim S. J., Park K., Brenner M., Messing A. Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus. J. Neuropathol. Expl. Neurol. 54:1995;339-349.
20. Games D., Adams D., Alessandrin R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice expressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
21. Gelbart W. M. The decapentaplegic gene: a TGF-β homologue controlling pattern formation in Drosophila. Development. 107 (suppl.):1989;65-74.
22. Goate A., Chartier-Harlin M. -C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation of the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
23. Gouin A., Bloch-Gallego E., Tanaka H., Rosenthal A., Henderson C. E. Transforming growth factor-beta 3, glial cell line-derived neurotrophic factor and fibroblast growth factor-2 act in different manners to promote motoneuron survival in vitro. J. Neurosci. Res. 43:1996;454-464.
24. Gray C. W., Patel A. J. Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1 beta in astrocytes. Brain Res. Mol. Brain Res. 19:1993;251-256.
25. Gross C. E., Bednar M. M., Howard D. B., Sporn M. B. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke. 24:1993;558-562.
26. Gruppuso P. A., Mikumo R., Brautigan D. L., Braun L. Growth arrest induced by transfoming growth factor beta 1 is accompanied by protein phosphatase activation in human keratinocytes. J. Biol. Chem. 266:1991;3444-3448.
27. Hamada Y., Ikata T., Katoh S., Katoh K., Niwa M., Tsutsumishita Y., Fukuzawa K. Effects of exogenons transforming growth factor-β1 on spiral cord injury in rats. Neurosci. Lett. 203:1996;97-100.
28. Harpel J. G., Metz C. N., Kojima S., Rifkin D. B. Control of transforming growth factor-β activity: latency vs activation. Prog. Growth Factor Res. 4:1992;321-335.
29. Henrich-Noack P., Prehn J. H. M., Krieglstein J. TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia; dose-response relationship and potential neuroprotective mechanisms. Stroke. 27:1996;1609-1615.
30. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., Butterfield D. A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl Acad. Sci. USA. 91:1994;3270-3274.
31. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
32. Hunter K. E., Sporn M. B., Davies A. M. Transforming growth factor-βs inhibit mitogen-stimulated proliferation of astrocytes. Glia. 7:1993;203-211.
33. Jakowlew S. B., Climent G., Tuan R. S., Sporn M. B., Roberts A. B. Expression of transforming growth factor-β2 and β3 mRNAs and proteins in the developing chicken embryo. Differentiation. 55:1994;105-118.
34. Jordan J., Galindo M. F., Prehn J. H. M., Weichselbaum R. R., Beckett M., Ghadge G. D., Roos R. P., Leiden J. M., Miller R. J. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci. 17:1997;1397-1405.
35. Kane C. J. M., Brown G. J., Phelan K. D. Transforming growth factor-β2 stimulates and inhibits neurogenesis of rat cerebellar granule cells in culture. Brain Res. Dev. Brain Res. 96:1996;46-51.
36. Kane C. J. M., Brown G. J., Phelan K. D. Transforming growth factor-β2 increases NMDA receptor-mediated excitotoxicity in rat cerebral cortical neurons independently of glia. Neurosci. Lett. 204:1996;93-96.
37. Kim S. J., Jeang K. T., Glick A. B., Sporn A. B., Roberts A. B. Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J. Biol. Chem. 264:1989;7041-7045.
38. Kingsley D. M. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
39. Klempt N. D., Sirimane E., Gunn A. J., Klempt M., Singh K., Williams C., Gluckman P. D. Hypoxia-ischemia induces transforming growth factor β1 mRNA in the infant rat brain. Brain Res. Molec. Brain Res. 13:1992;93-101.
40. Knuckey N. W., Finch P., Palm D. E., Primiano M. J., Johanson C. E., Flanders K. C., Thompson N. L. Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. Brain Res. Mol. Brain Res. 40:1996;1-14.
41. Krieglstein K., Unsicker K. Distinct modulatory action of TGF-β and LIF on neurotrophin-mediated survival of developing sensory neurons. Neurochem. Res. 21:1996;843-850.
42. + toxicity. EMBO J. 14:1995;736-742.
43. Krupinski J., Kumar P., Kumar S., Kaluza J. Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke. 27:1996;852-857.
44. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics. 9:1995;21-30.
45. Lafyatis R., Lechleider R., Kim S. J., Jakowlew S., Roberts A. B., Sporn M. B. Structural and functional characterization of the transforming growth factor beta 3 promoter. A c-AMP-responsive element regulates basal and induced transcription. J. Biol. Chem. 265:1990;19128-19136.
46. Laping N. J., Morgan T. E., Nichols N. R., Rozovsky I., Young-Chan C. S., Zarow C., Finch C. E. Transforming growth factor-β1 induces neuronal and astrocyte genes: tubulinα1, glial fibrillary acidic protein and clusterin. Neuroscience. 58:1994;563-752.
47. Lehrmann E., Kiefer R., Finsen B., Diemer N. H., Zimmer J., Harting H. -P. Cytokines in cerebral ischemia: expression of transforming growth factor beta-1 (TGF-β1) mRNA in the postischemic adult rat hippocampus. Exp. Neurol. 131:1995;114-123.
48. Lindholm D., Hengerer B., Zafra F., Thoenen H. Transforming growth factor-β1 stimulates expression of nerve growth factor in the rat CNS. NeuroReport. 1:1990;9-12.
49. Lindholm D., Castren D., Kiefer R., Zafra F., Theonen H. Transforming growth factor β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117:1992;395-400.
50. Lippa C. F., Smith T. W., Flanders K. C. Transforming growth factor-β: neuronal and glial expression in CNS degenerative diseases. Neurodegeneration. 4:1995;425-432.
51. Logan A., Frautschy S. A., Gonzalez A.-M., Sporn M. B., Baird A. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury. Brain Res. 587:1992;216-225.
52. Logan A., Berry M., Gonzalez A. M., Frautschy S. A., Sporn M. B., Baird A. Effects of transforming growth factor β1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6:1994;355-363.
53. Lorentzon M., Hoffer B., Ebendal T., Olson L., Tomac A. Habrec1, a novel serine/threonine kinase TGF-beta type I-like receptor, has a specific cellular expression suggesting function in the developing organism and adult brain. Expl. Neurol. 142:1996;351-360.
54. Markowitz S. D., Roberts A. B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7:1996;93-102.
55. Martinou J. -C., Le Van Thai A., Valette A., Weber M. J. Transforming growth factor-β1: a potent survival factor for rat embryo motoneurons in culture. Dev. Brain Res. 52:1990;175-181.
56. Massagué J. TGF-β signaling: receptors, transducers, and Mad proteins. Cell. 85:1996;947-950.
57. Massagué J., Attisano L., Wrana J. L. The TGF-β family and its composite receptors. Trends Cell Biol. 4:1994;172-178.
58. McNeill H., Williams C., Guan J., Dragunow M., Lawlor P., Sirimanne E., Nikolics K., Gluckman P. Neuronal rescue with transforming growth factor-β1 after hypoxic-ischaemic brain injury. NeuroReport. 5:1994;901-904.
59. Merrill J. E., Zimmerman R. P. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF-β Glia. 41:1991;327-331.
60. Meucci O., Miller R. J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1. J. Neurosci. 16:1996;4080-4088.
61. Mogi M., Harada M., Kondo T., Narabayashi H., Riederer P., Magatsu T. Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci. Lett. 193:1995;129-132.
62. Mönning U., Sandbrink R., Banati R. B., Masters C. L., Beyreuther K. Transforming growth factor β mediates increase of mature transmembrane amyloid precursor protein in microglial cells. FEBS Lett. 342:1994;267-272.
63. Morgan T. E., Nichols N. R., Pasinetti G. M., Finch C. E. TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Expl. Neurol. 120:1993;291-301.
64. Morganti-Kossman M. C., Kossman T., Brandes M. E., Mergehagen S. E., Wahl S. M. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β J. Neuroimmunol. 39:1992;163-174.
65. Mrak R. E., Sheng J. G., Griffin W. S. T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26:1995;816-823.
66. O'Reilly M. A., Geiser A. G., Kim S. J., Bruggeman L. A., Luu A. X., Roberts A. B., Sporn M. B. Identification of an activating transcription factor (ATF) binding site in human transforming growth factor-beta 2 promoter. J. Biol. Chem. 267:1992;19938-19943.
67. Pasinetti G. M., Nichols N. R., Tocco G., Morgan T., Laping N., Finch C. E. Transforming growth factor-β1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience. 54:1993;893-907.
68. Pelton R. W., Saxena B., Jones M., Moses H. L., Gold L. I. Immunohistochemical localization of TGFβ1, TGFβ2 and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115:1991;1091-1105.
69. Peress N. S., Perillo E. Differential expression of TGF-β 1, 2, 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Expl. Neurol. 54:1995;802-811.
70. Pleasure S. J., Page C., Lee V. M. Y. Pure, postmitotic, polarized human neurons derived from Ntera2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1992;1802-1815.
71. Poulson K. T., Armanini A. P., Klein R. D., Hynes M. A., Phillips H. S., Rosenthal A. TGF-β2 and TGF-β3 are potent survival factors for midbrain dopaminergic neurons. Neuron. 13:1994;1245-1252.
72. Prehn J. H. M., Miller R. J. Opposite effects of TGF-β1 on rapidly- and slowly-triggered excitotoxic injury. Neuropharmacology. 35:1996;249-256.
73. Prehn J. H. M., Backhauss C., Krieglstein J. Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13:1993;521-525.
74. Prehn J. H. M., Peruche B., Unsicker K., Krieglstein J. Isoform-specific effects of transforming growth factor-β on degeneration of primary neuronal cultures induced by cyotoxic hypoxia or glutamate. J. Neurochem. 60:1993;1665-1672.
75. Prehn J. H. M., Bindokas V. P., Marcuccilli C. J., Krajewski S., Reed J. C., Miller R. J. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection of rat hippocampal neurons. Proc. Natl Acad. Sci. USA. 91:1994;12599-12603.
76. Prehn J. H. M., Bindokas V. P., Jordan J., Galindo M. F., Ghadge G. D., Roos R. P., Boise L. H., Thompson C. B., Krajewski S., Reed J. C., Miller R. J. Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49:1996;319-328.
77. Ren R. F., Flanders K. C. Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide. Brain Res. 732:1996;16-24.
78. Ren R. F., Hawver D. B., Kim R. S., Flanders K. C. Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: involvement of the TGF-β type II receptor. Brain Res. Mol. Brain Res. 35:1997;315-322.
79. 2+: their relationship to apoptosis and oncogenesis. FEBS Lett. 325:1993;104-107.
80. Roberts A. B., Sporn M. B. Interrelationships between two superfamilies: the steroid/retinoid receptors and transforming growth factor-β Cancer Survival. 14:1992;205-219.
81. Roberts, A. B. and Sporn, M. B. (1996) Transforming growth factor-β. In: The Molecular and Cellular Biology of Wound Repair, 2nd Ed., pp. 275-308. Ed. R. A. F. Clark. Plenum: New York.
82. Roberts A. B., Anzano M. A., Lamb L. C., Smith J. M., Sporn M. B. New class of transforming growth factors potentiated by epidermal growth factor. Proc. Natl Acad. Sci. USA. 78:1981;5339-5343.
83. Saad B., Constam D. B., Ortmann R., Moos M., Fontana A., Schachner M. Astrocyte-derived TGF-β2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes. J. Cell Biol. 115:1991;473-484.
84. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons from striatal 6-hydroxydopamine lesions. Proc. Natl Acad. Sci. USA. 92:1995;8935-8939.
85. Schultz-Cherry S., Murphy-Ulrich J. E. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:1993;923-932.
86. Shah M., Foreman D. M., Furguson W. J. Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J. Cell. Sci. 108:1995;985-1002.
87. Sporn, M. B. and Roberts, A. B. (1990) The transforming growth factor-βs. In: Peptide Growth Factors and Their Receptors I, pp. 419-472. Eds M. B. Sporn and A. B. Roberts. Springer: New York.
88. Tada T., Kanaji M., Kobayashi S. Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β1. J. Neuroimmunol. 50:1994;153-158.
89. Tsuchida K., Sawchenko P. E., Nishikawa S., Vale W. W. Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain. Mol. Cell. Neurosci. 7:1996;467-478.
90. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-β Nature. 334:1988;260-262.
91. Unsicker K. GDNF: a cytokine at the interface of TGF-βs and neurotrophins. Cell Tissue Res. 286:1996;175-178.
92. Unsicker K., Flanders K. C., Cissel D. S., Lafyatis R., Sporn M. B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
93. Unsicker K., Meier C., Krieglstein K., Sartor B. M., Flanders K. C. Expression, localization and function of transforming growth factor-βs in the embryonic chick spinal cord, hindbrain, and dorsal root ganglia. J. Neurobiol. 29:1996;262-276.
94. Van der Wal E. A., Gomez-Pinilla F., Cotman C. W. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. NeuroReport. 4:1993;69-72.
95. Vawter M. P., Dillon-Carter O., Tourtellotte W. W., Carvey P., Freed W. J. TGF-β1 and TGF-β2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Expl. Neurol. 142:1996;313-322.
96. Vodovotz Y., Lucia M. S., Flanders K. C., Chesler L., Xie Q. -W., Smith T. W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A. B., Lippa C. F., Sporn M. B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Expl. Med. 184:1996;1425-1433.
97. Wang X., Yue T. -L., White R. F., Barone F. C., Feuerstein G. Z. Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res. Bull. 36:1995;607-609.
98. Wiessner C., Gehrmann J., Lindholm D., Topper R., Kreutzberg G. W., Hossmann K. A. Expression of transforming growth factor-β1 and interleukin-1β in rat brain following transient forebrain ischemia. Acta Neuropathol. 86:1993;439-446.
99. Wrana J. L., Attisano L., Wieser R., Ventura F., Massagué J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
100. Wyss-Coray T., Feng L., Masliah E., Ruppe M. D., Lee H. S., Toggas S. M., Rockenstein E. M., Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpresing transforming growth factor-β1. Am. J. Pathol. 147:1995;53-67.
101. Yao J., Harveth L., Gilbert D. L., Colton C. A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27:1990;36-42.